CT & MRI company Medic Vision Imaging Solutions Ltd revealed on Tuesday that it has passed the US Food and Drug Administration (FDA) clearance for latest product, iQMR (intelligent Quick MR), to save cost, improve its productivity and boost patients experience and profitability.
The company said the new iterative image reconstruction technology enhances noisy MRI images and significantly increases SNR (signal to noise ratio). The new technology's capabilities enable the use of short MRI protocols and allow increased productivity, fewer repeating scans as well as better patient's experience.
Concurrently, the iQMR supports MRI scanners of all vendors and models, according to the company.
Following the US FDA's clearance, the company will now launch the iQMR at the upcoming ASNR 56th Annual Meeting. Additionally, Prof Lawrence N Tanenbaum, MD, FACR, VP and director of CT, MR & Advanced Imaging at RadNet, will present the results of a clinical study demonstrating the ability to reduce routine brain exam scan time by 30% without adversely affecting image quality using iQMR.
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval